US › Healthcare

Baird Medical Investment Holdings Limited (BDMD)

US · Healthcare · Medical Devices

$0.09-44.13%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$9.9M

Revenue YoY

-58.5%

Net profit

$35,405

Profit YoY

-99.6%

Net margin

0.4%

Key statistics

Market cap

$6.0M

Forward P/E

1.8

P/B

0.23

Book value

$1.09

EPS (TTM)

$-0.55

52-week high

$3.70

52-week low

$0.13

50-day MA

$0.83

200-day MA

$1.34

Beta

-1.12

Analyst view

with an average price target of $4.00.

Shareholding

Insiders

86.31%

Institutions

0.99%

Largest institutional holders

Fund	Stake
UBS Group AG	0.18%
Two Sigma Investments LLC	0.17%
Renaissance Technologies Corp	0.17%
Citadel Advisors Llc	0.17%
Jane Street Group LLC	0.10%
NATIONAL BANK OF CANADA /FI/	0.09%
Geode Capital Management, LLC	0.06%
XTX Topco Ltd	0.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Baird Medical Investment Holdings Limited — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.